(Q35784063)

10 August 2017

1 reference

title

Review of the immunosuppressant enteric-coated mycophenolate sodium (English)

1 reference

10 August 2017

1 reference

0 references

0 references

Hans-Hellmut Neumayer

7

object named as

Hans-Hellmut Neumayer

1 reference

10 August 2017

Klemens Budde

1

1 reference

10 August 2017

Petra Glander

2

1 reference

10 August 2017

Fritz Diekmann

3

1 reference

10 August 2017

Johannes Waiser

4

1 reference

10 August 2017

Lutz Fritsche

5

1 reference

10 August 2017

Duska Dragun

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

1333-1345

1 reference

Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Impact of cyclosporine 2‐h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti‐thymocyte globulin induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Lung transplants with tacrolimus and mycophenolate mofetil: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Immunosuppressive activity of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mechanism of action of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

The use of mycophenolate mofetil in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Immunosuppressive drugs: the first 50 years and a glance forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Comparative efficacy of mycophenolate sodium (MPS) and mycophenolate mofetil (MMF) with and without cyclosporine in rat transplantation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolate sodium: tolerability and efficacy in transplantation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Tolerability profile of sodium mycophenolate (ERL080) and mycophenolate mofetil with and without cyclosporine (Neoral) in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Comparative gastrointestinal effects of mycophenolate mofetil capsules and enteric-coated tablets of sodium-mycophenolic acid in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Efficacy of mycophenolate sodium as monotherapy and in combination with FTY720 in a DA-to-Lewis-rat heart-transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Enteric-coated mycophenolate sodium: results of two pivotal global multicenter trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Mycophenolic Acid Pharmacodynamics and Pharmacokinetics Provide a Basis for Rational Monitoring Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Pharmacokinetics of mycophenolic acid in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Clinical pharmacokinetics of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Enteric-coated mycophenolate sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Therapeutic equivalence of mycophenolate sodium versus mycophenolate mofetil in de novo renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Steroid-free immunosuppression in kidney transplantation: an editorial review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

Drug interactions with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1333

10.1517/14656566.5.6.1333

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference